Advertisement
Screener

MYLAN INC. Form 425: Prospectus or communication for a business combination

Add as a preferred source on Google

MYLAN INC. Form 425: Prospectus or communication for a business combination

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2015-01-28: Form 425; Description FORM 8-K; Document d859374d8k.htm.
  • 2015-01-14: Form 425; Description FORM 8-K; Document d841123d8k.htm.
  • 2015-01-14: Form 425; Description 425; Document d850417d425.htm.
  • 2014-12-22: Form 425; Description 425; Document d838254d425.htm.
FiledFormPeriod of reportDescriptionDocument
2015-01-28425FORM 8-Kd859374d8k.htm
2015-01-14425FORM 8-Kd841123d8k.htm
2015-01-14425425d850417d425.htm
2014-12-22425425d838254d425.htm
2014-11-18425425d823415d425.htm
2014-11-05425FORM 8-Kd814757d8k.htm
2014-10-31425FORM 425d813795d425.htm
2014-10-224258-Kd809133d8k.htm
2014-10-22425425a14-22870_1425.htm
2014-10-224258-Ka14-22704_28k.htm
2014-08-13425425d772690d425.htm
2014-08-07425425d770630d425.htm
2014-07-17425425d757981d425.htm
2014-07-17425425d758508d425.htm
2014-07-16425425a14-17107_9425.htm
2014-07-16425425a14-17107_8425.htm
2014-07-14425FORM 425d757981d425.htm
2014-07-14425FORM 425d757997d425.htm
2014-07-14425FORM 425d758090d425.htm
2014-07-14425FORM 425d758096d425.htm
2014-07-14425FORM 8-Kd754717d8k.htm
2014-07-14425425a14-17107_7425.htm
2014-07-14425425a14-17107_6425.htm
2014-07-14425425a14-17107_5425.htm
2014-07-14425425a14-17107_4425.htm
2014-07-14425425a14-17107_3425.htm
2014-07-14425425a14-17107_2425.htm
2014-07-144258-Ka14-17107_18k.htm
2005-01-12425MYLAN LABORATORIES, INC.j1141301e425.txt
2004-12-22425MYLAN LABORATORIES INC.j1117301e425.htm
2004-12-22425MYLAN LABORATORIES, INC.j1116901e425.htm
2004-12-17425MYLAN LABORATORIES INC./KING PHARMACEUTICALS, INC.j1111901e425.htm
2004-12-16425MYLAN LABORATORIES INC.j1107901e425.htm
2004-12-13425MYLAN LABORATORIES, INC. 425j1104001e425.htm
2004-11-22425MYLAN LABORATORIES 425j1068201e425.htm
2004-11-19425MYLAN LABORATORIES, INC.j1067601e425.htm
2004-11-01425MYLAN LABORATORIES INC.j1031301e425.htm
2004-11-01425MYLAN LABORATORIES INC.j1032501e425.htm
2004-10-26425MYLAN LABORATORIES/KING PHARMACEUTICALS 425j1020801e425.htm
2004-10-25425MYLAN LABORATORIES INCj1016401e425.htm
2004-10-21425MYLAN LABORATORIES, INC.j1009501e425.htm
2004-10-19425MYLAN LABORATORIES, INC.j1004901e425.htm
2004-10-15425MYLAN LABORATORIES, INC.j1003301e425.htm
2004-10-15425MYLAN LABORATORIES, INC.j1000301e425.htm
2004-10-13425MYLAN LABORATORIES, INC./ KING PHARMACEUTICALS 425j0991901e425.htm
2004-10-13425MYLAN LABORATORIES, INC./ KING PHARMACEUTICALS 425j0991801e425.htm
2004-09-20425MYLAN LABORATORIES, INC.j0963801e425.htm
2004-09-14425MYLAN LABORATORIES INC./KING PHARMACEUTICALS, INC.j0958801e425.htm
2004-09-09425MYLAN LABORATORIES/ KING PHARMACEUTICALS, INC. 425j0953001e425.htm
2004-09-09425MYLAN LABORATORIES, INC.j0951401e425.htm
2004-09-08425MYLAN LABORATORIES, INC.j0948501e425.htm
2004-08-20425MYLAN LABORATORIES, INC.j0929501e425.htm
2004-08-02425MYLAN LABORATORIES, INC./KING PHARMACEUTICALS 425j0898801e425.htm
2004-07-26425MYLAN LABORATORIES, INC.j0887401e425.htm
2004-07-26425FILED PURSUANT TO RULE 425j0887301e425.htm
Advertisement